AI Article Synopsis

  • The study aimed to assess physician adherence to regional guidelines for diagnosing and treating lower lip squamous cell carcinoma over a span of eight years.
  • Compliance varied significantly, with adherence rates ranging from 4% to 80% across different aspects of care, including diagnosis, treatment, and follow-up.
  • The findings indicated that a limited number of patients received guideline-concordant care, underscoring the need for regular evaluations and updates of the guidelines to improve their application in practice.

Article Abstract

Objective: To investigate to what extent physicians comply with a regional guideline for the diagnosis, staging, treatment and follow-up of patients with squamous cell carcinoma of the lower lip.

Design: Retrospective analysis of data from the medical records of 248 patients diagnosed with squamous cell carcinoma of the lower lip during the period 1989-1997.

Setting: Comprehensive Cancer Centre of the Northern region of the Netherlands.

Study Participants: The data were collected by this Centre for the regional population-based cancer registry.

Results: Overall compliance with the separate guidelines varied between 4 and 80%. For diagnosis and staging, the guideline was followed for 4-70% of patients. The type of treatment in relation to age conformed to the guideline in 34% of cases. Of the 208 surgically-treated patients, treatment was performed in accordance with the guidelines in 92 (44%) patients, compared with seven out of 18 (39%) patients who received radiotherapy. Follow-up in accordance with the guideline was 11% in the first year, 9% in the second year and 21% in the third year.

Conclusion: Only a minority of patients with squamous cell carcinoma of the lower lip, a rare rumour, were managed according to the available regional guideline. Regular review of both the guideline and its implementation is necessary in order to optimize its use.

Download full-text PDF

Source
http://dx.doi.org/10.1093/intqhc/13.2.143DOI Listing

Publication Analysis

Top Keywords

squamous cell
16
cell carcinoma
16
regional guideline
12
carcinoma lower
12
guideline diagnosis
8
diagnosis staging
8
patients squamous
8
lower lip
8
patients
7
guideline
6

Similar Publications

Understanding how epithelial cells in the female reproductive tract (FRT) differentiate is crucial for reproductive health, yet the underlying mechanisms remain poorly defined. At birth, FRT epithelium is highly malleable, allowing differentiation into various epithelial types, but the regulatory pathways guiding these early cell fate decisions are unclear. Here, we use neonatal mouse endometrial organoids and assembloid coculture models to investigate how innate cellular plasticity and external mesenchymal signals influence epithelial differentiation.

View Article and Find Full Text PDF

Potential trend of regenerative treatment for type I diabetes has been introduced for more than a decade. However, the technologies regarding insulin-producing cell (IPC) production and transplantation are still being developed. Here, we propose the potential IPC production protocol employing mouse gingival fibroblast-derived induced pluripotent stem cells (mGF-iPSCs) as a resource and the pre-clinical approved subcutaneous IPC transplantation platform for further clinical confirmation study.

View Article and Find Full Text PDF

Aflatoxin B1 (AFB1) is a class 1 carcinogen and mycotoxin known to contribute to the development of hepatocellular carcinoma (HCC), growth impairment, altered immune system modulation, and malnutrition. AFB1 is synthesized by Aspergillus flavus and is known to widely contaminate foodstuffs, particularly maize, wheat, and groundnuts. The mechanism in which AFB1 causes genetic mutations has been well studied, however its metabolomic effects remained largely unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!